Context Therapeutics Inc.
CNTX
Revenue
0.00
0.000.00%
-Assets
102.71M
▲91.66M▲829.35%
3 Months ChangeLiabilities
1.60M
▼-1.00M▼-38.49%
3 Months ChangeFree Cash Flow
-5.73M
▼-1.87M▼-48.59%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0001842952-24-000083
2024-09-17
Form 8-K
ID: 0001842952-24-000081
2024-09-04
Form 8-K
ID: 0001842952-24-000070
2024-08-07
Form 10-Q
ID: 0001842952-24-000065
2024-07-10
Form 8-K
ID: 0001842952-24-000050
2024-06-14
Form 8-K
ID: 0001842952-24-000041
2024-05-08
Form 10-Q
ID: 0001842952-24-000035
2024-05-02
Form 8-K
ID: 0001842952-24-000033
2024-04-01
Form 8-K
ID: 0001842952-24-000022
2024-03-21
Form 8-K
ID: 0001842952-24-000010